HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Approval of issue and allotment of equity shares of the Company on exercise of Employee Stock Options.19-08-2023
19-08-2023
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings call held on August 11, 2023 with Analysts / Investors to discuss the unaudited financial results for the quarter ended June 30, 202318-08-2023
HealthCare Global Enterprises Ltd - 539787 - Appointment Of Ms. Ruby Ritolia As CFO And KMP Of The Company
Appointment of Ms. Ruby Ritolia as CFO and KMP of the Company effective from August 21, 2023.18-08-2023
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Retirement
Mr. Srinivasa V Raghavan, CFO and KMP of the Company, will cease to hold the position as the CFO and KMP effective from August 20, 2023, on account of his retirement from the Company.18-08-2023
Q1FY24 Quarterly Result Announced for Healthcare Global Enterprises Ltd.
Healthcare Global Enterprises announced Q1FY24 results: Revenue of Rs 4,607 million in Q1FY24, up 13% YoY. EBITDA of Rs 764 million in Q1FY24, up 5% YoY. Profit After Tax of Rs 110 million in Q1FY24, up 17% YoY. Overall ARPOB stood at Rs 39,686 vs. Rs 38,286 in Q1FY23. Overall AOR stood at 66.9% vs. 61.0% in Q1FY23, a rise of 590 bps. Commenting on the results, Dr. B.S. Ajaikumar, Executive Chairman, HealthCare Global Enterprises said, “HCG’s oncology network, through its presence and depth, uniquely positions the company to address the growing cancer burden in India holistically, while delivering quality cancer care and outcomes. HCG's role today goes beyond mere service provision, extending into pioneering research and academia. We consistently encourage our medical professionals to delve into research, clinical trials, and active participation in global medical conferences and academic pursuits. We are currently working on the low dose immunotherapy & also collaborating with various MNC’s for developing technologies and AI based framework for treatments. HCG strives to be the trusted healthcare partner for every individual battling cancer. We are honored to have earned the trust of our patients and the communities we serve and remain committed to upholding that trust every day." Result PDF14-08-2023
How cancer care chain HCG was nurtured to wellness
In February 2021, it hired Raj Gore a seasoned healthcare industry professional as CEO of the company. Gore has since then focussed on improving efficiency, enhancing profitability by leveraging its scale of operations.13-08-2023
HealthCare Global Enterprises Ltd - 539787 - Announcement Under Regulation 30- Earnings Call Recording
Further to our intimation dated July 27, 2023, this is to inform the Stock Exchange(s) that the audio recording of Earnings Call held on August 11, 2023, with Analysts /Investors to discuss the Unaudited Financial Reuslts of the quarter ended June 30, 2023, is made available on the website of the Company www.hcgoncology.com11-08-2023
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Unaudited Financial Results of the Company for the quarter ended June 30, 2023.11-08-2023
Healthcare Global reports net profit of 3.65 crore
The Bengaluru-based hospital chain experienced a growth of 12.86 per cent in revenues from operations11-08-2023
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on Unaudited FInancial Results (Standlaone and COnsolidated) of the Company for the quarter ended June 30, 2023.10-08-2023